N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties

Protein Science

Volumn 9, Issue 12, 2000, Pages 2547-2556

  Saviranta, Petri ^a   Jauria, Piitu ^a,c   Lamminmäki, Urpo ^a   Hellman, Jukka ^b   Eriksson, Susann ^a   Lövgren, Timo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^c Innotrac Diagnostics Oy   (Finland)

Author keywords

Estradiol; N terminus; Recombinant antibodies; Steroid recognition

Indexed keywords

ESTRADIOL; ESTRADIOL ANTIBODY; HAPTEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; RECOMBINANT ANTIBODY; STEROID; TESTOSTERONE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; GENE MUTATION; HYBRIDOMA; IMMUNOGLOBULIN GENE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS);

EID: 0034492577     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.12.2547     Document Type: Article

References (29)

1. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site
2. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3
3. Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding
4. Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognition
5. Antibody framework residues affecting the conformation of the hypervariable loops
6. Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli
7. Europium as a label in time-resolved immunofluorometric assays
8. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
9. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda
10. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity
11. Engineered turns of a recombinant antibody improve its in vivo folding
12. Structural analysis of an anti-estradiol antibody
13. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge
14. The introduction of strain and its effects on the structure and stability of T4 lysozyme
15. Antibody-antigen interactions: Contact analysis and binding site topography
16. Structural families in loops of h6mologous proteins: Automatic classification, modelling and application to antibodies
17. Engineering disulfide-linked single-chain Fv dimers [(sFv′)2] with improved solution and targeting properties: Anti-digoxin 26-10 (sFv′)2 and anti-c-erbB-2 741F8 (sFv′) 2 made by protein folding and bonded through C-terminal cysteinyl peptides
18. Synthesis of novel europium-labeled estradiol derivatives for time-resolved fluoroimmunoassays
19. Labeling of estradiol and testosterone alkyloxime derivatives with a europium chelate for time-resolved fluoroimmunoassays
20. The synthesis and use of activated N-benzyl derivatives of diethylenetriaminetetraacetic acids: Alternative reagents for labeling of antibodies with metal ions
21. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
22. Cloning, sequencing, expression and characterization of three antiestradiol-17beta Fab fragments
23. Effect of heavy chain signal peptide mutations and NH2-terminal chain length on binding of anti-digoxin antibodies
24. Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNA library
25. Engineering the steroid-specificity of an anti-17beta-estradiol Fab by random mutagenesis and competitive phage panning
26. Contribution of antibody heavy chain CDR1 to digoxin binding analyzed by random mutagenesis of phage-displayed Fab 26-10
27. Antibody-antigen interactions
28. Antibody-antigen interactions: New structures and new conformational changes